Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related event
Related Products
Reset
TitlePublishedTypeProducts
How important is expert review when measuring EC3 predictions in Derek Nexus?: Alkyl halides - a case studyMarch 2017pdf fileDerek Nexus
How Meteor Nexus Predicts - Detailed.pdfJuly 2016pdf fileMeteor Nexus
How Meteor Nexus Predicts.pdfJuly 2016pdf fileMeteor Nexus
How Sarah Nexus PredictsMarch 2014Sarah Nexus
How Sarah Nexus Predicts - DetailedMarch 2014Sarah Nexus
How To - Filtering Mass DefectDecember 2014Meteor Nexus
How to Become a New Member of Lhasa.pdfFebruary 2015pdf file
How to discover new structural alerts and recognise new secondary molecular attributes that modulate alert effectivenessOctober 2016pdf fileDerek Nexus
ICH M7 - Have you got it covered?March 2015Derek NexusMirabilisSarah NexusVitic NexusZeneth
ICH M7 - Worked Examples using the new Nexus workflowMarch 2016pdf fileDerek NexusSarah Nexus
ICH M7 BrochureMarch 2016pdf fileDerek NexusSarah NexusVitic NexusZeneth
ICH M7 Classification and the involvement of (Q)SAR methodsOctober 2016pdf fileDerek NexusSarah Nexus
ICH M7 Classification WorkflowMarch 2017pdf fileDerek NexusSarah Nexus
ICH M7 How Lhasa can support you.pdfMarch 2014pdf fileDerek Nexus
ICH M7 Workflow.pdfNovember 2015pdf fileDerek NexusSarah NexusVitic Nexus
ICH Q3D: Practical implementation and the role of excipient data in a risk based approachDecember 2016
ICH Quality Guidelines: An Implementation GuideOctober 2017
Identification of Adverse Outcome Pathways for the Nephrotoxicity of Nucleoside and Nucleotide Anti-Viral DrugsMarch 2014pdf fileDerek Nexus
Impact from the Recent Issuance of ANVISA Resolution RDC-53/2015 on Pharmaceutical Small Molecule Forced Degradation Study RequirementsMay 2016Zeneth
Implementation of ICH M7 Recommended (Q)SAR AnalysesMarch 2016pdf fileDerek NexusSarah NexusVitic NexusZeneth
Importance of Comprehensive Reporting of (Q)SAR Assessments Under ICH M7.pdfMarch 2015pdf file
Important Considerations When Building Statistical-based Mutagenicity Models.pdfNovember 2015pdf fileSarah Nexus
Improvements to in silico mutagenicity predictivity of aromatic amines with access to proprietary dataMarch 2016pdf fileDerek Nexus
Improvements to in silico predictivity after access to proprietary dataApril 2016Derek Nexus
Improvements to In Silico Skin Sensitization Predictivity After Access to Proprietary DataMarch 2016pdf fileDerek Nexus

© 2017 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

QuestionPro supports sample survey questions such as multiple choice, drop-down menu, likert-scale, semantic differential, matrix, constant sum, drag-and-drop, slider-scale, net-promoter scale, and many more question types.